| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.26 | 9e-08 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.23 | 3e-06 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-06 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.25 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 3e-05 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-05 |